Cytori Therapeutics (CYTX)

Create an Alert
2.33 +0.01  +0.43%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

Cytori Therapeutics SG&A Expense Quarterly:

6.265M for Dec. 31, 2012
View Full Chart

Cytori Therapeutics SG&A Expense Quarterly Chart

    Cytori Therapeutics Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 6.265M
    Sept. 30, 2012 6.227M
    June 30, 2012 6.369M
    March 31, 2012 6.30M
    Dec. 31, 2011 6.497M
    Sept. 30, 2011 7.156M
    June 30, 2011 7.863M
    March 31, 2011 6.77M
    Dec. 31, 2010 6.923M
    Sept. 30, 2010 5.992M
    June 30, 2010 5.477M
    March 31, 2010 5.217M
    Dec. 31, 2009 5.342M
    Sept. 30, 2009 4.104M
    June 30, 2009 3.772M
    March 31, 2009 3.78M
    Dec. 31, 2008 3.576M
    Sept. 30, 2008 4.406M
    June 30, 2008 4.279M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    CYTX SG&A Expense Quarterly Benchmarks

    Companies
    Athersys 1.507M
    Medivation 41.91M
    Osiris Therapeutics 2.889M

    CYTX SG&A Expense Quarterly Rankings

    Overall 72nd percentile
    4678 of 16773
    Sector 71st percentile
    395 of 1408 in Healthcare
    Industry 81st percentile
    84 of 453 in Biotechnology

    CYTX SG&A Expense Quarterly Range, Past 5 Years

    Minimum 3.576M Dec 2008
    Maximum 7.863M Jun 2011
    Average 5.596M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');